251 related articles for article (PubMed ID: 18369324)
1. Stem and progenitor cell-mediated tumor selective gene therapy.
Aboody KS; Najbauer J; Danks MK
Gene Ther; 2008 May; 15(10):739-52. PubMed ID: 18369324
[TBL] [Abstract][Full Text] [Related]
2. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
4. [Mesenchymal stem cells as an antitumor therapy tool].
Karshieva SSh; Krasikov LS; Beliavskiĭ AV
Mol Biol (Mosk); 2013; 47(1):50-60. PubMed ID: 23705495
[TBL] [Abstract][Full Text] [Related]
5. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.
Danks MK; Yoon KJ; Bush RA; Remack JS; Wierdl M; Tsurkan L; Kim SU; Garcia E; Metz MZ; Najbauer J; Potter PM; Aboody KS
Cancer Res; 2007 Jan; 67(1):22-5. PubMed ID: 17210679
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-based gene therapy for brain tumors.
Kim SU
Stem Cell Rev Rep; 2011 Mar; 7(1):130-40. PubMed ID: 20521177
[TBL] [Abstract][Full Text] [Related]
8. Development of a tumor-selective approach to treat metastatic cancer.
Aboody KS; Bush RA; Garcia E; Metz MZ; Najbauer J; Justus KA; Phelps DA; Remack JS; Yoon KJ; Gillespie S; Kim SU; Glackin CA; Potter PM; Danks MK
PLoS One; 2006 Dec; 1(1):e23. PubMed ID: 17183650
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment with VPA and MSCs‑TRAIL could increase anti‑tumor effects against intracranial glioma.
Park SA; Han HR; Ahn S; Ryu CH; Jeun SS
Oncol Rep; 2021 Mar; 45(3):869-878. PubMed ID: 33469674
[TBL] [Abstract][Full Text] [Related]
10. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
[TBL] [Abstract][Full Text] [Related]
11. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic gene products delivery by neuron stem cells.
Tan J; Meng Y; Huang S; Wang P
Curr Pharm Biotechnol; 2012 Sep; 13(12):2427-31. PubMed ID: 23016647
[TBL] [Abstract][Full Text] [Related]
13. Harnessing mesenchymal stem cell homing as an anticancer therapy.
Hagenhoff A; Bruns CJ; Zhao Y; von Lüttichau I; Niess H; Spitzweg C; Nelson PJ
Expert Opin Biol Ther; 2016 Sep; 16(9):1079-92. PubMed ID: 27270211
[TBL] [Abstract][Full Text] [Related]
14. Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas.
Fan S; Gao H; Ji W; Zhu F; Sun L; Liu Y; Zhang S; Xu Y; Yan Y; Gao Y
J Cell Physiol; 2020 Feb; 235(2):1769-1779. PubMed ID: 31301067
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
17. Prodrug cancer gene therapy.
Altaner C
Cancer Lett; 2008 Nov; 270(2):191-201. PubMed ID: 18502571
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
[TBL] [Abstract][Full Text] [Related]
19. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
O'Brien KP; Khan S; Gilligan KE; Zafar H; Lalor P; Glynn C; O'Flatharta C; Ingoldsby H; Dockery P; De Bhulbh A; Schweber JR; St John K; Leahy M; Murphy JM; Gallagher WM; O'Brien T; Kerin MJ; Dwyer RM
Oncogene; 2018 Apr; 37(16):2137-2149. PubMed ID: 29367765
[TBL] [Abstract][Full Text] [Related]
20. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL.
Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA
Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
